# IMATINIB MESYLATE
> **ANDA212135** · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2022-06-21
## Drug
- **FDA Application Number:** ANDA212135
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IMATINIB MESYLATE
- **Generic name:** IMATINIB MESYLATE
- **Active ingredients:** IMATINIB MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QILU PHARM HAINAN
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2022-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212135)
---
*MORVS · CC0 1.0*